binx health receives EUA authorizing At-Home COVID-19 sample collection by universities and employers
Latest amendment adds important tool for student health and employers in the fight against COVID-19
NEWS
FDA grants binx health CLIA-Waiver for its first-of-kind binx io platform for chlamydia and gonorrhea testing
News
College health insurer Wellfleet teams up with binx health to keep students safe and campuses open in the fight against COVID-19
Wellfleet taps binx for convenient, in-dorm sample collection and bespoke technology solutions to help arrest virus spread
Sherlock Biosciences and binx health Announce Global Partnership to Develop First CRISPR-based Point-of-care Test for COVID-19
binx health’s Proven Molecular io Platform Combined with SHERLOCK™ CRISPR Technology Will Enable Rapid, Accurate Testing for SARS-CoV-2 in Retail and Near-patient Settings
binx health and UPS Jointly Announce International Partnership for At-home “Contactless” COVID-19 Sample Collection
Binx and UPS Healthcare pair advanced infectious disease testing with superior global logistics to reach populations everywhere, starting in the United Kingdom
binx health Announces Publication of Pivotal Study in JAMA Network Open
Study signals “real paradigm shift” in care resulting from the world’s first FDA-cleared, 30-minute, molecular point-of-care platform for the detection of chlamydia and gonorrhea
binx health Announces Second FDA 510(k) Clearance of its Molecular Point-of-Care Infectious Disease Platform
Latest FDA clearance establishes binx as the fastest dual-gender rapid test-and-treat platform for chlamydia and gonorrhea
COVID-19 pandemic has created growing backlog of millions in need of routine STI testing
Fortune Magazine featured binx health’s io as a healthcare “breakthrough,” as it expands access to high quality chlamydia and gonorrhea testing at point of care sites across the US
binx health was featured in Fortune Magazine highlighting the io platform as not only the first and fastest FDA-cleared molecular point-of-care diagnostic for the detection of chlamydia and gonorrhea, but…
Given market demand, binx health announces launch of pre-order program for its first-of-kind rapid, molecular point-of-care platform
binx offers first FDA 510(k) cleared molecular point-of-care solution for test and treat of sexually-transmitted infections in a single visit
